IPI vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
IPI exhibits strong deterministic health with a Piotroski F-Score of 7/9 and a nearly debt-free balance sheet (Debt/Equity 0.01). However, the stock is significantly overvalued relative to its Graham Number ($26.75) and Intrinsic Value ($5.95), trading at a steep premium. While explosive YoY EPS growth (+545.5%) and a PEG ratio of 0.96 provide a growth-based justification, the bearish technical trend and a lone analyst target of $25.00 suggest a high risk of price correction.
Newmont Corporation presents a dichotomy between strong operational fundamentals and significant valuation premiums. While the Piotroski F-Score of 4/9 indicates stable health and the balance sheet is pristine with a Debt/Equity ratio of 0.17, the stock trades at a substantial premium to its Graham Number ($66.88) and Intrinsic Value ($44.73). Recent quarterly earnings beats are impressive, yet bearish insider sentiment and a 0/100 technical trend suggest a lack of immediate conviction from internal stakeholders and market momentum. The overall outlook is neutral as strong profitability is offset by overvaluation and negative insider signals.
Compare Another Pair
Related Comparisons
IPI vs NEM: Head-to-Head Comparison
This page compares Intrepid Potash, Inc. (IPI) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.